Does Tocotrienols Skin Hydration Randomized Trial work?

Updated July 2026

Quick Answer

Tocotrienols Skin Hydration Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Results According to the repeated-measures ANOVA, the control and study group had a significant reduction in follicular papule counts over time (all p Conclusion The combined formula effectively reduced follicular papules, improved skin hydration, decreased TEWL, and alleviated depressive symptoms in KP patients.

Key Takeaways

  • 01Results According to the repeated-measures ANOVA, the control and study group had a significant reduction in follicular papule counts over time (all p Conclusion The combined formula effectively reduced follicular papules, improved skin hydration, decreased TEWL, and alleviated depressive symptoms in KP patients. [Liu F (2026)]
  • 02Objective Keratosis pilaris (KP) is a common follicular keratotic skin disorder characterized by follicular papules and skin roughness, often accompanied by itching and inflammation, significantly affecting appearance and psychological health. [Liu F (2026)]
  • 03Methods This 28-day prospective, open-label, randomized controlled study evaluated the effectiveness of a novel combined formula for KP treatment. [Liu F (2026)]
  • 04This research aims to investigate the efficacy of tocotrienol-rich fraction (TRF) on various health parameters associated with general well-being in individuals aged between 50 years and 75 years. [Amir Razak NAN (2025)]
The current Migaku evidence database contains 2 reusable source documents for Tocotrienols Skin Hydration Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Results According to the repeated-measures ANOVA, the control and study group had a significant reduction in follicular papule counts over time (all p Conclusion The combined formula effectively reduced follicular papules, improved skin hydration, decreased TEWL, and alleviated depressive symptoms in KP patients. [Liu F (2026); evidence level 2] - Objective Keratosis pilaris (KP) is a common follicular keratotic skin disorder characterized by follicular papules and skin roughness, often accompanied by itching and inflammation, significantly affecting appearance and psychological health. [Liu F (2026); evidence level 2] - Methods This 28-day prospective, open-label, randomized controlled study evaluated the effectiveness of a novel combined formula for KP treatment. [Liu F (2026); evidence level 2] - This research aims to investigate the efficacy of tocotrienol-rich fraction (TRF) on various health parameters associated with general well-being in individuals aged between 50 years and 75 years. [Amir Razak NAN (2025); evidence level 2] - Background Tocotrienol, a naturally occurring form of vitamin E, has been extensively studied for its potent antioxidant, anti-inflammatory, and immune-stimulating properties. [Amir Razak NAN (2025); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. An Innovative Formula for Keratosis Pilaris Treatment-A Randomized Controlled Study Based on the "Exfoliation-Dissolution-Repair" Concept.
  2. Effectiveness of Tocotrienol-Rich Fraction in Older Adults: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial.